BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FXYD4
,
calcium channel activity
,
Arthritis
,
Hypothalamus
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DLL4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Pancreas
Vena cava
Heart ventricle
Fetal liver
Transverse colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Delta like 4 regulates cerebrovascular development and endothelial integrity via DLL4-NOTCH-CLDN5 pa…
Polyethylenimine Triggers Dll4 Degradation to Regulate Angiogenesis In Vitro.
DLL4/Notch blockade disrupts mandibular advancement-induced condylar osteogenesis by inhibiting H-ty…
2nd Window NIR Imaging of Radiation Injury Mitigation Provided by Reduced Notch-Dll4 Expression on V…
DLL4 promotes partial endothelial-to-mesenchymal transition at atherosclerosis-prone regions of arte…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or…
Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic B…
Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)
A Phase 1 Study of OMP-305B83 in Subjects With Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ